![]() | |
| Clinical data | |
|---|---|
| Other names | 2C-VI; 4-Ethenyl-2,5-dimethoxyphenethylamine; 4-Vinyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-ethenylphenethylamine; 2,5-Dimethoxy-4-vinylphenethylamine |
| Routes of administration | Oral1 |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| Pharmacokinetic data | |
| Duration of action | 5 hours1 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H17NO2 |
| Molar mass | 207.273 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2C-V, or 2C-VI, also known as 4-ethenyl-2,5-dimethoxyphenethylamine, is a recreational designer drug from the substituted phenethylamine family, with psychedelic effects. It was first synthesised by Daniel Trachsel and colleagues in 2006. It is active at a dosage of 25 mg orally with a duration of around 5 hours.1 It is a controlled substance in Canada under phenethylamine blanket-ban language.2
References
References
- Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine Von der Struktur zur Funktion [Phenethylamine From structure to function] (in German). Nachtschatten Verlag AG. p. 766-771. ISBN 978-3-03788-700-4.
- "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
